Asimov private stock trade

Asimov

Legal NameAsimov, Inc.
HeadquartersBoston, MA
SectorBioTech

Developer of a mammalian cell engineering platform designed to accelerate the design and manufacture of biologics and gene therapies. The company's platform combines synthetic biology, biophysical simulations, and machine learning-based design to engineer genetic circuits for their respective use in the field of biotechnology, enabling clients to optimize the printing and design of genetic logic gates and create advanced manufacturing and therapeutics applications.

Learn more about Asimov IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Asimov, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Asimov, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.